Feb 6, 2019

Potential Alzheimer’s Therapy UB-311 Safe, Effective, Phase 2a Trial Finds

Posted by in categories: biotech/medical, neuroscience

United Neuroscience’s Alzheimer’s vaccine candidate UB-311 was found safe and well-tolerated, triggering an antibody response against beta-amyloid in most of the patients, according to Phase 2a trial results.


Read more

Comments are closed.